Publication | Open Access

Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer

Breast OncologyOncologyMedicineGynecologyAromataseMenopausePharmacotherapyBreast CancerPlasma Oestrogen LevelsEndocrinologyPharmacologyVivo AromatisationSteroid MetabolismEndocrine-related Cancer